Brimonidine 0.2 %

DRUG2 trials

Sponsors

Medical University of Vienna, Zagazig University

Conditions

GlaucomaIntraocular PressureOcular Physiology

Early Phase 1

Optic Nerve Perfusion Following Treatment with Latanoprost Versus Brimionidin Tartrate

CompletedNCT06730516

Zagazig UniversityGlaucoma

Start: 2024-06-24End: 2024-10-01Updated: 2024-12-12

Unknown Phase

Relation Between Intraocular Pressure Lowering Effects of Topical Brimonidine and Alpha 2 Receptor Polymorphism

WithdrawnNCT00712777

Medical University of ViennaIntraocular Pressure, Ocular Physiology

Start: 2008-03-31End: 2014-11-30Updated: 2014-11-21